Inactief instrument

Andere talen Addex Therapeutics Ltd Xetra

Aandelen

ADDEX THERAPEUTICS : INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Form 6 K	06/06
Addex Therapeutics' Q1 Net Loss Widens; Revenue Down	06/06
Morning Briefing - Markt Schweiz	06/06
Financé jusqu'en 2026, Addex creuse sa perte au 1er trimestre	06/06
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update	06/06
Addex Convenes Annual General Meeting 2024	05/06
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024	31/05
Addex to Present at BioEURquity Europe 2024	08/05
Addex to Present at Bio€quity Europe 2024	08/05
European Equities Traded in the US as American Depositary Receipts Decline	30/04
Sector Update: Health Care Stocks Edge Higher Late Afternoon	29/04
Sector Update: Health Care	29/04
Top Midday Decliners	29/04
Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal	29/04
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	29/04
Top Premarket Decliners	29/04
Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure	29/04
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	29/04
Addex essuie un échec en étude clinique intermédiaire contre l'épilepsie	29/04
Addex erleidet Forschungsrückschlag mit Epilepsie-Kandidaten	29/04

Geen resultaten voor deze zoekopdracht